CN105456864A - Traditional Chinese medicine decoction for treating hashimoto thyroiditis - Google Patents
Traditional Chinese medicine decoction for treating hashimoto thyroiditis Download PDFInfo
- Publication number
- CN105456864A CN105456864A CN201510986982.0A CN201510986982A CN105456864A CN 105456864 A CN105456864 A CN 105456864A CN 201510986982 A CN201510986982 A CN 201510986982A CN 105456864 A CN105456864 A CN 105456864A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- radix
- traditional chinese
- medicine decoction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine decoction for treating hashimoto thyroiditis. The traditional Chinese medicine decoction is prepared from the following traditional Chinese medicine raw materials in parts by weight: 33 to 46 parts of radix knoxiae, 31 to 39 parts of sauropus spatulifolius beille, 25 to 36 parts of radix rehmanniae, 22 to 29 parts of cornua cervi pantotrichum, 18 to 27 parts of the root of red-rooted salvia, 12 to 27 parts of pokeberry root, 8 to 16 parts of the root of three-nerved spicebush, 5 to 12 parts of rhizoma kaempferiae, 3 to 9 parts of rhizoma cyperi, 2 to 8 parts of scutellaria baicalensis, 3 to 8 parts of honey-fried licorice root and 2 to 7 parts of herb of pilosella-leaved drymoglossum. According to the traditional Chinese medicine decoction provided by the invention, all components are pure traditional Chinese medicine and are used in combination for soothing liver and regulating Qi, tonifying spleen and nourishing blood, promoting blood circulation to remove blood stasis and resolving hard lump, the traditional Chinese medicine decoction has protection and restoration effects on thyroid tissues, can effectively relieve patient symptoms, and has no adverse reactions and toxic and side effects, the effective rate is 92.5 percent, and the aim of treating early hashimoto thyroiditis without being concomitant with thyroid dysfunctions is realized.
Description
Technical field
The present invention relates to a kind of Chinese medicine decoction for the treatment of chronic lymphocytic thyroiditis.
Background technology
Chronic lymphocytic thyroiditis (HT) is a kind of autoimmune thyroid disease common clinically, histologic characteristics due to primary disease show as diffusivity lymphocytic infiltration, fibrosis, interstitial atrophy and acinous cell acidophilia change, therefore also referred to as chronic lymphocytic thyroiditis.Primary disease is apt to occur in 30 ~ 50 years old women, and its sickness rate is in the trend increased gradually in recent years.Current western medical treatment primary disease takes thyroxin alternative medicine, immunotherapy, operative treatment etc. more, curative effect affirmative, but untoward reaction is many, and easily recurs.The Chinese medicine decoction treatment chronic lymphocytic thyroiditis that the present invention prepares, achieves good effect.
Summary of the invention
Technical problem to be solved by this invention is: provide that a kind of therapeutic effect is good, effective percentage is high, Chinese medicine decoction to the treatment chronic lymphocytic thyroiditis of human non-toxic's side effect.
For solving the problems of the technologies described above, the technical solution used in the present invention is:
The Chinese medicine decoction for the treatment of chronic lymphocytic thyroiditis provided by the invention, is made up of the raw material of Chinese medicine of following weight portion: Radix Knoxiae 33-46 part, Folium Sauropi 31-39 part, Radix Rehmanniae 25-36 part, Cornu Cervi Pantotrichum 22-29 part, Radix Salviae Miltiorrhizae 18-27 part, Radix Phytolaccae 12-27 part, Radix Linderae 8-16 part, Rhizoma Kaempferiae 5-12 part, Rhizoma Cyperi 3-9 part, Radix Scutellariae 2-8 part, Radix Glycyrrhizae Preparata 3-8 part, Drymoglossum Herba Drymoglossi 2-7 part.
Preferably, Chinese medicine provided by the invention is made up of the raw material of Chinese medicine of following weight portion: Radix Knoxiae 40 parts, Folium Sauropi 33 parts, 30 parts, the Radix Rehmanniae, 26 parts, Cornu Cervi Pantotrichum, Radix Salviae Miltiorrhizae 21 parts, Radix Phytolaccae 17 parts, the Radix Linderae 11 parts, Rhizoma Kaempferiae 8 parts, Rhizoma Cyperi 5 parts, Radix Scutellariae 5 parts, Radix Glycyrrhizae Preparata 6 parts, Drymoglossum Herba Drymoglossi 4 parts.
Usage and dosage: above-mentioned raw materials, is simmered in water after boiling with high heat 30 minutes after 10 minutes with warm water soaking again, taking liquid 150 milliliters, then add water and two to decoct, filter after twice medicinal liquid mixing, take at twice.Twice daily, one after each meal.
The course for the treatment of: 15 days be a course for the treatment of, the 2-5 course for the treatment of need be taken.
Clinical report is as follows: 1, in the routine patient of physical data 100, women 41 example, male 59 example.2, the scleroid goiter of diagnostic criteria (1) diffusivity.(2) TgAb (thyroglobulin antibody) and TmAb (thyroid microsomal antibody) significantly increases or reduces with FT4 (serum free thyroxine), FT3 (free serum 3).(3) thyroid fine needle pathology examination by centesis.3, medicinal warm water soaking in of the present invention after 10 minutes, simmers in water after boiling with high heat 30 minutes by Therapeutic Method again, taking liquid 150 milliliters, then adds water and two to decoct, and filters, take after twice medicinal liquid mixing at twice.Twice daily, one after each meal.
The course for the treatment of: 15 days be a course for the treatment of, the 2-5 course for the treatment of need be taken.
4, therapeutic outcome: 4.1 with reference to " Chinese medical disease Standardization of diagnosis and curative effect ": cure: clinical symptom disappearance, thyroid is without enlargement, and TgAb, TmAb, FT4, FT3 level is normal; Take a turn for the better: clinical symptoms obviously alleviates, and thyromegaly reduces is on close level normally more than 50%, TgAb, TmAb, FT4, FT3; Effective: clinical symptoms alleviates to some extent, thyromegaly reduces, and TgAb, TmAb, FT4, FT3 level is improved; Do not heal: goiter is reduced not obvious or without reducing, TgAb, TmAb, FT4, FT3 are unchanged or increase the weight of.4.2 results: in 100 routine patients, cure 80 examples, and take a turn for the better 11 examples, and effective 6 examples, total effective rate is 97%.
Beneficial effect of the present invention:
The various component of the present invention is pure Chinese medicine; all medicines share depressed liver-energy dispersing and QI regulating, strengthening spleen and nourishing blood, blood circulation promoting and blood stasis dispelling, hard masses softening and resolving; to parathyroid tissue, there is protection and repair; effective improvement or patients in remission; reach treatment early stage, without chronic lymphocytic thyroiditis's object of dysthyreosis, have no adverse reaction and toxic and side effects.
Detailed description of the invention
Embodiment 1
The Chinese medicine decoction of the treatment chronic lymphocytic thyroiditis that the present embodiment provides, is made up of the raw material of Chinese medicine of following weight portion: Radix Knoxiae 40 parts, Folium Sauropi 33 parts, 30 parts, the Radix Rehmanniae, 26 parts, Cornu Cervi Pantotrichum, Radix Salviae Miltiorrhizae 21 parts, Radix Phytolaccae 17 parts, the Radix Linderae 11 parts, Rhizoma Kaempferiae 8 parts, Rhizoma Cyperi 5 parts, Radix Scutellariae 5 parts, Radix Glycyrrhizae Preparata 6 parts, Drymoglossum Herba Drymoglossi 4 parts.
Model case:
1. Huang, female, 37 years old, the enlargement of bilateral thyroid II degree.After having taken 2 courses for the treatment of of Chinese medicine of the present invention, all diseases of goiter have all been improved.Check thyroid function has recovered normal, TGAb and TPOAb declines to some extent.Continue to take 3 courses for the treatment of, each index recovers normal, and disease obtains recovery from illness.
2. high certain, man, 49 years old, during health check-up, B ultrasonic found thyroid moderate swelling, no conscious sympton.Chemical examination display TGAb, TPOAb raise, and FT3, FT4, TSH are normal; After taking 2 courses for the treatment of of this medicine, TGAb, TPOAb obviously decline, fine needle aspiration display thyroid follicle size structure comparatively before normal, proliferation of fibrous tissue degree alleviates.Continue 3 courses for the treatment of of taking medicine, TGAb, TPOAb are normal, recovery from illness.
Claims (2)
1. treat a Chinese medicine decoction for chronic lymphocytic thyroiditis, it is characterized in that, be made up of the raw material of Chinese medicine of following weight portion: Radix Knoxiae 33-46 part, Folium Sauropi 31-39 part, Radix Rehmanniae 25-36 part, Cornu Cervi Pantotrichum 22-29 part, Radix Salviae Miltiorrhizae 18-27 part, Radix Phytolaccae 12-27 part, Radix Linderae 8-16 part, Rhizoma Kaempferiae 5-12 part, Rhizoma Cyperi 3-9 part, Radix Scutellariae 2-8 part, Radix Glycyrrhizae Preparata 3-8 part, Drymoglossum Herba Drymoglossi 2-7 part.
2. Chinese medicine according to claim 1, is characterized in that, is made up of the raw material of Chinese medicine of following weight portion: Radix Knoxiae 40 parts, Folium Sauropi 33 parts, 30 parts, the Radix Rehmanniae, 26 parts, Cornu Cervi Pantotrichum, Radix Salviae Miltiorrhizae 21 parts, Radix Phytolaccae 17 parts, the Radix Linderae 11 parts, Rhizoma Kaempferiae 8 parts, Rhizoma Cyperi 5 parts, Radix Scutellariae 5 parts, Radix Glycyrrhizae Preparata 6 parts, Drymoglossum Herba Drymoglossi 4 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510986982.0A CN105456864A (en) | 2015-12-26 | 2015-12-26 | Traditional Chinese medicine decoction for treating hashimoto thyroiditis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510986982.0A CN105456864A (en) | 2015-12-26 | 2015-12-26 | Traditional Chinese medicine decoction for treating hashimoto thyroiditis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105456864A true CN105456864A (en) | 2016-04-06 |
Family
ID=55595313
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510986982.0A Pending CN105456864A (en) | 2015-12-26 | 2015-12-26 | Traditional Chinese medicine decoction for treating hashimoto thyroiditis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105456864A (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102670915A (en) * | 2012-05-31 | 2012-09-19 | 王中英 | Traditional Chinese medicine combination for treating hashimoto thyroiditis |
-
2015
- 2015-12-26 CN CN201510986982.0A patent/CN105456864A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102670915A (en) * | 2012-05-31 | 2012-09-19 | 王中英 | Traditional Chinese medicine combination for treating hashimoto thyroiditis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101411848B (en) | Black plaster for treating gland hyperplasia and preparation method thereof | |
| CN102836339B (en) | Medicine for treating diabetic nephropathy | |
| CN101940716A (en) | Medicament for treating diabetic nephropathy | |
| CN103705878B (en) | One treats migraine Chinese medicine preparation | |
| CN104173546A (en) | Traditional Chinese medicine liquid for treating rhinitis | |
| CN1046421C (en) | Drug for curing pulmonary tuberculosis | |
| CN104013806A (en) | Traditional Chinese medicine composition for treating diabetes mellitus | |
| CN103656077A (en) | Traditional Chinese medicine compound combination with function of curing chronic kidney diseases | |
| CN1792372A (en) | Traditional Chinese medicine prepn. for treating diabetes | |
| CN103212013B (en) | Chinese medicinal composition for treating epigastric pain | |
| CN102552520A (en) | Blood circulation-promoting and pain-stopping medicament for treating chest stuffiness and pains and preparation process and application thereof | |
| CN105456864A (en) | Traditional Chinese medicine decoction for treating hashimoto thyroiditis | |
| CN105343370A (en) | Traditional Chinese medicine preparation for treating migraine | |
| CN104688872A (en) | Traditional Chinese medicine composition for treating hypothyroidism | |
| CN101502597B (en) | Medicament for treating stomachache and preparation method thereof | |
| CN105477493A (en) | Traditional Chinese medicine composition for treating Hashimoto's thyroiditis | |
| CN105381418A (en) | Traditional Chinese medicine preparation for treating hashimoto thyroiditis | |
| CN102920864B (en) | Chinese medicament for treating cerebrovascular diseases | |
| CN103405524B (en) | Cancellous bone-reinforcing formula for treating osteoporosis and preparation technology of same | |
| CN103007236B (en) | Chinese medicinal composition for treating ankylosing spondylitis | |
| CN103432333B (en) | Composition consisting of effective traditional Chinese medicine parts and used for treating hypothyroidism | |
| CN102366594A (en) | Traditional Chinese medicine for adjusting menstruation | |
| CN101953943A (en) | Traditional Chinese medicine for treating chronic aplastic anemia | |
| CN102319375A (en) | Medicine for treating cervical spondylopathy and preparation method thereof | |
| CN101983676A (en) | Medicament for treating gynecological blood stasis and qi stagnation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160406 |